FCRL1 encodes a member of the immunoglobulin receptor superfamily and has been identified as a potential biomarker for prognosis and a therapeutic target in diffuse large B cell lymphoma (DLBCL) treatment.54 Here, FCRL1 is linked to diffuse large B-cell lymphoma.